OBJECTIVE: Interleukin-10 is an anti-inflammatory cytokine that reduces periapical bone loss, but its role in periodontal bone loss is unclear. In the present study, we tested the hypothesis that endogenous interleukin-10 is a potent suppressor of Porphyromonas gingivalis-induced alveolar bone loss in vivo. METHODS: Interleukin-10 knockout (-/-) and wild-type mice were inoculated intraorally with P. gingivalis. Non-infected animals served as negative controls. Alveolar bone loss, gingival cytokine levels, and gingival gene expression were assessed using morphometric analysis, enzyme-linked immunosorbent assay (ELISA), and semiquantitative reverse transcription polymerase chain reaction (RT-PCR), respectively. RESULTS: P. gingivalis-infected interleukin-10(-/-) mice exhibited severe alveolar bone loss compared to non-infected interleukin-10(-/-) and wild-type mice by day 42. Surprisingly, bone resorptive cytokines interleukin-1alpha and tumor necrosis factor alpha (TNF-alpha) were not up-regulated in gingival tissues by P. gingivalis-infection. Although interleukin-1beta was marginally increased, blockade of both interleukin-1 isoforms or interleukin-1 receptor type I with neutralizing antisera failed to reduce alveolar bone loss in interleukin-10(-/-) mice, indicating the operation of an interleukin-1-independent mechanism. No strong correlations between bone loss and other cytokines was observed, although interferon gamma (IFNgamma), interleukin-6, interleukin-4, and prostaglandin E2 were modestly up-regulated in infected interleukin-10(-/-) mice. P. gingivalis infection reduced the expression of cell markers in gingival tissue on days 7 and 14 in both interleukin-10(-/-) and wild-type animals, suggestive of bacteria-induced cytotoxicity or apoptosis. This was followed by up-regulated expression of receptor activator of nuclear factor kappa B ligand (RANKL) and CD40 ligand (CD40L on days 28 and 70 in infected interleukin-10(-/-) mice only. CONCLUSION: The interleukin-10(-/-) mouse is highly susceptible to bone loss induced by the periodontal pathogen P. gingivalis, which is mediated via an interleukin-1-independent pathway. (c)Blackwell Munksgaard 2004
OBJECTIVE:Interleukin-10 is an anti-inflammatory cytokine that reduces periapical bone loss, but its role in periodontal bone loss is unclear. In the present study, we tested the hypothesis that endogenous interleukin-10 is a potent suppressor of Porphyromonas gingivalis-induced alveolar bone loss in vivo. METHODS:Interleukin-10 knockout (-/-) and wild-type mice were inoculated intraorally with P. gingivalis. Non-infected animals served as negative controls. Alveolar bone loss, gingival cytokine levels, and gingival gene expression were assessed using morphometric analysis, enzyme-linked immunosorbent assay (ELISA), and semiquantitative reverse transcription polymerase chain reaction (RT-PCR), respectively. RESULTS: P. gingivalis-infectedinterleukin-10(-/-) mice exhibited severe alveolar bone loss compared to non-infectedinterleukin-10(-/-) and wild-type mice by day 42. Surprisingly, bone resorptive cytokines interleukin-1alpha and tumornecrosis factor alpha (TNF-alpha) were not up-regulated in gingival tissues by P. gingivalis-infection. Although interleukin-1beta was marginally increased, blockade of both interleukin-1 isoforms or interleukin-1 receptor type I with neutralizing antisera failed to reduce alveolar bone loss in interleukin-10(-/-) mice, indicating the operation of an interleukin-1-independent mechanism. No strong correlations between bone loss and other cytokines was observed, although interferon gamma (IFNgamma), interleukin-6, interleukin-4, and prostaglandin E2 were modestly up-regulated in infected interleukin-10(-/-) mice. P. gingivalis infection reduced the expression of cell markers in gingival tissue on days 7 and 14 in both interleukin-10(-/-) and wild-type animals, suggestive of bacteria-induced cytotoxicity or apoptosis. This was followed by up-regulated expression of receptor activator of nuclear factor kappa B ligand (RANKL) and CD40 ligand (CD40L on days 28 and 70 in infected interleukin-10(-/-) mice only. CONCLUSION: The interleukin-10(-/-) mouse is highly susceptible to bone loss induced by the periodontal pathogen P. gingivalis, which is mediated via an interleukin-1-independent pathway. (c)Blackwell Munksgaard 2004
Authors: Srinivas R Myneni; Rajendra P Settem; Terry D Connell; Achsah D Keegan; Sarah L Gaffen; Ashu Sharma Journal: J Immunol Date: 2011-06-01 Impact factor: 5.422
Authors: W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li Journal: J Periodontal Res Date: 2016-01-11 Impact factor: 4.419
Authors: Vladimir Ilievski; Jason M Kinchen; Ramya Prabhu; Fadi Rim; Lara Leoni; Terry G Unterman; Keiko Watanabe Journal: J Oral Biol (Northborough) Date: 2016-04-23
Authors: Liang Hao; Jianwei Chen; Zheng Zhu; Michael S Reddy; John D Mountz; Wei Chen; Yi-Ping Li Journal: J Periodontol Date: 2015-04-16 Impact factor: 6.993
Authors: A Meka; V Bakthavatchalu; S Sathishkumar; M C Lopez; R K Verma; S M Wallet; I Bhattacharyya; B F Boyce; M Handfield; R J Lamont; H V Baker; J L Ebersole; L Kesavalu Journal: Mol Oral Microbiol Date: 2010-02 Impact factor: 3.563
Authors: Reginaldo B Gonçalves; Onir Leshem; Karen Bernards; John R Webb; Philip P Stashenko; Antonio Campos-Neto Journal: Infect Immun Date: 2006-07 Impact factor: 3.441
Authors: Philip Stashenko; Reginaldo B Gonçalves; Brad Lipkin; Alexander Ficarelli; Hajime Sasaki; Antonio Campos-Neto Journal: Am J Pathol Date: 2007-01 Impact factor: 4.307
Authors: Christina O Igboin; Kevin P Tordoff; Melvin L Moeschberger; Ann L Griffen; Eugene J Leys Journal: Infect Immun Date: 2010-11-01 Impact factor: 3.441
Authors: A Izawa; Y Ishihara; H Mizutani; S Kobayashi; H Goto; E Okabe; H Takeda; Y Ozawa; Y Kamiya; Y Sugita; K Kubo; H Kamei; T Kikuchi; A Mitani; J Hayashi; T Nishihara; H Maeda; T Noguchi Journal: Infect Immun Date: 2014-02-24 Impact factor: 3.441